Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib.

Nyga R, Simon L, Chouaki T, Delette C, Bennis Y, Joseph C, Marolleau JP, Slama M, Zogheib E, Maizel J.

Crit Care. 2019 Mar 12;23(1):88. doi: 10.1186/s13054-019-2385-x. No abstract available.

2.

Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection.

Zogheib E, Nyga R, Cornu M, Sendid B, Monconduit J, Jounieaux V, Maizel J, Segard C, Chouaki T, Dupont H.

Lung. 2018 Feb;196(1):65-72. doi: 10.1007/s00408-017-0067-5. Epub 2017 Dec 22.

PMID:
29273833
3.

Targeting the Unfolded Protein Response as a Potential Therapeutic Strategy in Renal Carcinoma Cells Exposed to Cyclosporine A.

Bodeau S, Sauzay C, Nyga R, Louandre C, Descamps V, François C, Godin C, Choukroun G, Galmiche A.

Anticancer Res. 2017 Mar;37(3):1049-1057.

PMID:
28314264
4.

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib.

Houessinon A, Gicquel A, Bochereau F, Louandre C, Nyga R, Godin C, Degonville J, Fournier E, Saidak Z, Drullion C, Barbare JC, Chauffert B, François C, Pluquet O, Galmiche A.

Cancer Lett. 2016 Jan 28;370(2):242-9. doi: 10.1016/j.canlet.2015.10.032. Epub 2015 Nov 3.

PMID:
26546044
5.

Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.

Marcq I, Nyga R, Cartier F, Amrathlal RS, Ossart C, Ouled-Haddou H, Ghamlouch H, Galmiche A, Chatelain D, Lamotte L, Debuysscher V, Fuentes V, Nguyen-Khac E, Regimbeau JM, Marolleau JP, Latour S, Bouhlal H.

PLoS One. 2013 Dec 20;8(12):e82918. doi: 10.1371/journal.pone.0082918. eCollection 2013.

6.

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.

Bouchekioua A, Scourzic L, de Wever O, Zhang Y, Cervera P, Aline-Fardin A, Mercher T, Gaulard P, Nyga R, Jeziorowska D, Douay L, Vainchenker W, Louache F, Gespach C, Solary E, Coppo P.

Leukemia. 2014 Feb;28(2):338-48. doi: 10.1038/leu.2013.157. Epub 2013 May 21.

PMID:
23689514
7.

The tumor suppressor hTid1 inhibits STAT5b activity via functional interaction.

Dhennin-Duthille I, Nyga R, Yahiaoui S, Gouilleux-Gruart V, Régnier A, Lassoued K, Gouilleux F.

J Biol Chem. 2011 Feb 18;286(7):5034-42. doi: 10.1074/jbc.M110.155903. Epub 2010 Nov 24.

8.

Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias.

Harir N, Pecquet C, Kerenyi M, Sonneck K, Kovacic B, Nyga R, Brevet M, Dhennin I, Gouilleux-Gruart V, Beug H, Valent P, Lassoued K, Moriggl R, Gouilleux F.

Blood. 2007 Feb 15;109(4):1678-86. Epub 2006 Oct 12.

9.

The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation.

Pecquet C, Nyga R, Penard-Lacronique V, Smithgall TE, Murakami H, Régnier A, Lassoued K, Gouilleux F.

Oncogene. 2007 Mar 8;26(11):1577-85. Epub 2006 Sep 4.

PMID:
16953222
10.

Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.

Nyga R, Pecquet C, Harir N, Gu H, Dhennin-Duthille I, Régnier A, Gouilleux-Gruart V, Lassoued K, Gouilleux F.

Biochem J. 2005 Aug 15;390(Pt 1):359-66.

11.

[Development and evaluation of a spectroscopy system for classification of laser-induced arterial fluorescence spectra].

Morguet AJ, Andreas S, Gabriel RE, Nyga R, Kreuzer H.

Biomed Tech (Berl). 1997 Jun;42(6):176-82. German.

PMID:
9312308
12.

Single-laser approach for fluorescence guidance of excimer laser angioplasty at 308 nm: evaluation in vitro and during coronary angioplasty.

Morguet AJ, Gabriel RE, Buchwald AB, Werner GS, Nyga R, Kreuzer H.

Lasers Surg Med. 1997;20(4):382-93.

PMID:
9142677
13.
14.

Ultrafast imaging of tissue ablation by a XeCl excimer laser in saline.

Preisack MB, Neu W, Nyga R, Wehrmann M, Haase KK, Karsch KR.

Lasers Surg Med. 1992;12(5):520-7.

PMID:
1406005
15.

In-line holography with a frequency doubled Nd:YAG laser for particle size analysis.

Nyga R, Schmitz E, Lauterborn W.

Appl Opt. 1990 Aug 10;29(23):3365-8. doi: 10.1364/AO.29.003365.

PMID:
20567421

Supplemental Content

Support Center